New study of Phase II Alzheimer's drug pipeline reveals more ways to combat disease

A new analysis of the Phase II Alzheimer’s drug pipeline, conducted by ResearchersAgainstAlzheimer’s, revealed 57 new Alzheimer’s drugs. According to the analysis, nearly twice as many mechanisms of action are being tested in Phase II than in Phase III clinical trials.

from Dementia Big http://ift.tt/2dQykc6 via alcoholic dementia

http://ift.tt/2dAxORo